AMO-04

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAMO-04
Drug Alias NameAMO-04
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamates modulators
TargetsGlutamates
Therapy Area/IndicationsRett Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAmo Pharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAmo Pharma
Inactive CompaniesN/A
Active IndicationsRett Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A